Structure Therapeutics宣布启动口服小分子淀粉样蛋白A受体激动剂Accg-2671的第一阶段临床研究以治疗肥胖症

美股速递
Dec 17, 2025

Structure Therapeutics宣布启动口服小分子淀粉样蛋白A受体激动剂Accg-2671的第一阶段临床研究以治疗肥胖症

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10